Open to: Academic | Student

Speaker: Dr Beth Payne

Myelodysplastic syndrome (MDS), or myelodysplasia, is a blood disorder that causes a drop in your number of healthy blood cells. MDS covers a spectrum of disorders from indolent (slow developing) to aggressive (that rapidly develop or change into leukaemia).

Consultant haematologist Dr Beth Payne who specialises in treating patients with myelodysplastic syndromes and bone marrow failure. She is also a Senior Clinical Researcher funded by the Wellcome Trust and The Leuka John Goldman Fellowship for future Science and runs a research laboratory studying the mechanisms of disease in bone marrow failure and myelodysplastic syndromes and is also working to develop novel therapeutics.

The conversation will focus on managing the condition from diagnosis to treatment. Questions related to all aspects of myelodysplastic syndromes and related conditions are welcome.

Contact

Submit questions
webmaster@uclh.nhs.uk

Links

Register here